TARGET Trademark

Trademark Overview

On Friday, November 4, 2022, a trademark application was filed for TARGET with the United States Patent and Trademark Office. The USPTO has given the TARGET trademark a serial number of 76760201. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, April 8, 2026. This trademark is owned by GenKOre Inc.. The TARGET trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Preparations for the treatment of muscle fatigue; vitamins for animals; dietary supplements for animals; dietary supplement drink mixes; royal jelly dietary supplements; dietary supplements consisting of trace elements; non-prescription medicines, namely, pills for the treatment of genetic disorder diseases; vitamin and mineral preparations for medical use; crude medicines for the treatment of genetic disorder diseases; anoretics being appetite suppressants; appetite suppressants; appetite stimulant preparations; dietary supplements; vitamin preparations in the nature of food supplements; nervines being tranquilizer; dietary supplements consisting of amino acids; pharmaceuticals for the treatment of genetic disorder diseases; antidepressants

Structural and functional analysis of genomes; development of biological preparations; research in the field of gene analysis; scientific research in the field of genetics and genetic engineering
target

General Information

Serial Number76760201
Word MarkTARGET
Filing DateFriday, November 4, 2022
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, April 8, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPreparations for the treatment of muscle fatigue; vitamins for animals; dietary supplements for animals; dietary supplement drink mixes; royal jelly dietary supplements; dietary supplements consisting of trace elements; non-prescription medicines, namely, pills for the treatment of genetic disorder diseases; vitamin and mineral preparations for medical use; crude medicines for the treatment of genetic disorder diseases; anoretics being appetite suppressants; appetite suppressants; appetite stimulant preparations; dietary supplements; vitamin preparations in the nature of food supplements; nervines being tranquilizer; dietary supplements consisting of amino acids; pharmaceuticals for the treatment of genetic disorder diseases; antidepressants
Goods and ServicesStructural and functional analysis of genomes; development of biological preparations; research in the field of gene analysis; scientific research in the field of genetics and genetic engineering

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 8, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 8, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenKOre Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressKR

Trademark Events

Event DateEvent Description
Wednesday, April 8, 2026REQUEST FOR TRANSFORMATION PROCESSED - TOTAL
Wednesday, April 8, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

target dietary supplements preparations genetic treatment disorder diseases appetite analysis medicines